Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sirolimus Market

Sirolimus Market Share

Report ID: GMI8726
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Sirolimus Market Share

The sirolimus industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Sirolimus Market Companies

Some of the eminent market participants operating in the sirolimus industry include:

Accord Healthcare Limited
Apotex Inc.
Amneal Pharmaceuticals, Inc.
Actiza Pharmaceutical Private Limited
Biocon Limited
Concept Medical
Concord Biotech
Dr. Reddy's Laboratories Ltd.
Intas Pharmaceuticals Ltd.
Livzon Pharmaceuticals Group Inc.
Pfizer Inc.
Tiefenbacher API + Ingredients GmbH & Co. KG
Torrent Pharmaceuticals Ltd.
Zydus Group

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Sirolimus market size crossed USD 270.7 million in 2023 and is expected to reach over USD 370.4 million by 2032 owing to the increasing prevalence of organ transplants and promising pipeline for different indications worldwide.

The organ transplant rejection segment recorded USD 120.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its immunosuppressive properties and anti-proliferative effects on vascular smooth muscle cells.

North America sirolimus industry exceeded 109.7 million in 2023 due to the presence of state-of-the-art medical facilities, research institutions, and pharmaceutical companies in the region.

Apotex Inc., Concord Biotech, Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Livzon Pharmaceuticals Group Inc., Pfizer Inc., Tiefenbacher API + Ingredients GmbH & Co. KG, Torrent Pharmaceuticals Ltd., and Zydus Group, are some of the major sirolimus companies worldwide.